Nanobiotix (NASDAQ:NBTX) Shares Gap Up – What’s Next?

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s stock price gapped up prior to trading on Wednesday. The stock had previously closed at $24.14, but opened at $25.69. Nanobiotix shares last traded at $26.4850, with a volume of 4,546 shares trading hands.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Guggenheim initiated coverage on Nanobiotix in a report on Tuesday, September 15th. They set a “buy” rating and a $64.00 price target for the company. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $46.67.

Nanobiotix Stock Up 13.0%

The company has a 50 day moving average of $33.62 and a 200-day moving average of $36.47.

Nanobiotix Company Profile

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.